Alamar Biosciences Inc.
ALMR | NASDAQ
$29.27
-$1.33 (-4.35%)
Nov 2, 2026, 11:22 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Net Income | -29.82M |
Depreciation & Amortization | 3.86M |
Stock-Based Compensation | 2.87M |
Other Working Capital | -2.72M |
Other Non-Cash Items | 2.05M |
Deferred Income Tax | n/a |
Change in Working Capital | -32.57M |
Operating Cash Flow | -53.61M |
Capital Expenditures | -6.38M |
Cash Acquisitions | n/a |
Purchase of Investments | -4.94M |
Sales Maturities Of Investments | 57.5M |
Other Investing Acitivies | -1.01M |
Investing Cash Flow | 46.18M |
Debt Repayment | 10M |
Common Stock Repurchased | n/a |
Dividend Paid | n/a |
Other Financial Acitivies | -657K |
Financial Cash Flow | 10.84M |
Net Cash Flow | 3.23M |
Free Cash Flow | -59.99M |
Adj. Free Cash Flow | -62.86M |
Maintenance CapEx | -6.38M |
Growth CapEx | n/a |
Owner Earnings | -59.99M |
Add to Watchlist
Select watchlists to add or remove ALMR